Fundamental and clinical studies of cefotiam in the field of pediatrics

Hironobu Akita; Yukio Iwasaki; Satoshi Iwata; Takafumi Kanemitsu; Haruki Hattori; Keiji Jozaki; Masahiro Hotta; Naoya Yamashita; Seiichiro Nanri; Yoshibumi Kojima; Noriyoshi Hara; Keisuke Sunagawa; Tadao Oikawa; Takashi Iwata; Mitsuru Osano; Yasuo Ichihashi

doi:10.11553/antibiotics1968b.34.723

Fundamental and clinical studies of cefotiam in the field of pediatrics

Hironobu Akita, Yukio Iwasaki, Satoshi Iwata, Takafumi Kanemitsu, Haruki Hattori, Keiji Jozaki, Masahiro Hotta, Naoya Yamashita, Seiichiro Nanri, Yoshibumi Kojima, Noriyoshi Hara, Keisuke Sunagawa, Tadao Oikawa, Takashi Iwata, Mitsuru Osano, Yasuo Ichihashi

Department of Infectious Diseases

Research output: Contribution to journal › Article

5 Citations (Scopus)

Abstract

The fundamental and clinical studies on cefotiam (CTM) were performed in the field of pediatrics, and the following results were obtained: 1. The peak MICs of CTM against Gram negative rods such as E. coli, Klebsiella, Salmonella, Proteus were 1.56mcg/ml. The MIC distribution against S. aureus was almost equal to the conventional cephalosporin antibiotics. The MICs against P. seudomonas and Serratia were over 400mcg/ml. 2. The mean serum levels of CTM after bolus intravenous injection of 25mg/kg were 59.9mg/ml after 15 min., 30.0mcg/ml after 30min., 15.6mcg/ml after 1 hour. 3. Administration of CTM to 6 pediatric patients produced the clinical responses which were good in all 6 cases and the bacterial effects of eradication in 3 cases and superinfection in the 2 cases in the 5 cases from whom the organism were isolated. No side effect was observed. From the above results, it is considered that a bolus injection of CTM 25 mg/kg t. i. d. to q. i. d. is a safe and useful treatment for pediatric cases.

Original language	English
Pages (from-to)	723-728
Number of pages	6
Journal	the japanese journal of antibiotics
Volume	34
Issue number	5
DOIs	https://doi.org/10.11553/antibiotics1968b.34.723
Publication status	Published - 1981 Jan 1

ASJC Scopus subject areas

Microbiology (medical)
Pharmacology (medical)
Infectious Diseases

Access to Document

10.11553/antibiotics1968b.34.723

Fingerprint Dive into the research topics of 'Fundamental and clinical studies of cefotiam in the field of pediatrics'. Together they form a unique fingerprint.

Cite this

Akita, H., Iwasaki, Y., Iwata, S., Kanemitsu, T., Hattori, H., Jozaki, K., Hotta, M., Yamashita, N., Nanri, S., Kojima, Y., Hara, N., Sunagawa, K., Oikawa, T., Iwata, T., Osano, M., & Ichihashi, Y. (1981). Fundamental and clinical studies of cefotiam in the field of pediatrics. the japanese journal of antibiotics, 34(5), 723-728. https://doi.org/10.11553/antibiotics1968b.34.723

Fundamental and clinical studies of cefotiam in the field of pediatrics. / Akita, Hironobu; Iwasaki, Yukio; Iwata, Satoshi; Kanemitsu, Takafumi; Hattori, Haruki; Jozaki, Keiji; Hotta, Masahiro; Yamashita, Naoya; Nanri, Seiichiro; Kojima, Yoshibumi; Hara, Noriyoshi; Sunagawa, Keisuke; Oikawa, Tadao; Iwata, Takashi; Osano, Mitsuru; Ichihashi, Yasuo.

In: the japanese journal of antibiotics, Vol. 34, No. 5, 01.01.1981, p. 723-728.

Research output: Contribution to journal › Article

Akita, H, Iwasaki, Y, Iwata, S, Kanemitsu, T, Hattori, H, Jozaki, K, Hotta, M, Yamashita, N, Nanri, S, Kojima, Y, Hara, N, Sunagawa, K, Oikawa, T, Iwata, T, Osano, M & Ichihashi, Y 1981, 'Fundamental and clinical studies of cefotiam in the field of pediatrics', the japanese journal of antibiotics, vol. 34, no. 5, pp. 723-728. https://doi.org/10.11553/antibiotics1968b.34.723

Akita, Hironobu ; Iwasaki, Yukio ; Iwata, Satoshi ; Kanemitsu, Takafumi ; Hattori, Haruki ; Jozaki, Keiji ; Hotta, Masahiro ; Yamashita, Naoya ; Nanri, Seiichiro ; Kojima, Yoshibumi ; Hara, Noriyoshi ; Sunagawa, Keisuke ; Oikawa, Tadao ; Iwata, Takashi ; Osano, Mitsuru ; Ichihashi, Yasuo. / Fundamental and clinical studies of cefotiam in the field of pediatrics. In: the japanese journal of antibiotics. 1981 ; Vol. 34, No. 5. pp. 723-728.

@article{c2b010d0056340a9b398335f83ca0440,

title = "Fundamental and clinical studies of cefotiam in the field of pediatrics",

abstract = "The fundamental and clinical studies on cefotiam (CTM) were performed in the field of pediatrics, and the following results were obtained: 1. The peak MICs of CTM against Gram negative rods such as E. coli, Klebsiella, Salmonella, Proteus were 1.56mcg/ml. The MIC distribution against S. aureus was almost equal to the conventional cephalosporin antibiotics. The MICs against P. seudomonas and Serratia were over 400mcg/ml. 2. The mean serum levels of CTM after bolus intravenous injection of 25mg/kg were 59.9mg/ml after 15 min., 30.0mcg/ml after 30min., 15.6mcg/ml after 1 hour. 3. Administration of CTM to 6 pediatric patients produced the clinical responses which were good in all 6 cases and the bacterial effects of eradication in 3 cases and superinfection in the 2 cases in the 5 cases from whom the organism were isolated. No side effect was observed. From the above results, it is considered that a bolus injection of CTM 25 mg/kg t. i. d. to q. i. d. is a safe and useful treatment for pediatric cases.",

author = "Hironobu Akita and Yukio Iwasaki and Satoshi Iwata and Takafumi Kanemitsu and Haruki Hattori and Keiji Jozaki and Masahiro Hotta and Naoya Yamashita and Seiichiro Nanri and Yoshibumi Kojima and Noriyoshi Hara and Keisuke Sunagawa and Tadao Oikawa and Takashi Iwata and Mitsuru Osano and Yasuo Ichihashi",

year = "1981",

month = jan,

day = "1",

doi = "10.11553/antibiotics1968b.34.723",

language = "English",

volume = "34",

pages = "723--728",

journal = "The Journal of antibiotics. Ser. B",

issn = "0368-2781",

publisher = "Japan Antibiotics Research Association",

number = "5",

}

TY - JOUR

T1 - Fundamental and clinical studies of cefotiam in the field of pediatrics

AU - Akita, Hironobu

AU - Iwasaki, Yukio

AU - Iwata, Satoshi

AU - Kanemitsu, Takafumi

AU - Hattori, Haruki

AU - Jozaki, Keiji

AU - Hotta, Masahiro

AU - Yamashita, Naoya

AU - Nanri, Seiichiro

AU - Kojima, Yoshibumi

AU - Hara, Noriyoshi

AU - Sunagawa, Keisuke

AU - Oikawa, Tadao

AU - Iwata, Takashi

AU - Osano, Mitsuru

AU - Ichihashi, Yasuo

PY - 1981/1/1

Y1 - 1981/1/1

N2 - The fundamental and clinical studies on cefotiam (CTM) were performed in the field of pediatrics, and the following results were obtained: 1. The peak MICs of CTM against Gram negative rods such as E. coli, Klebsiella, Salmonella, Proteus were 1.56mcg/ml. The MIC distribution against S. aureus was almost equal to the conventional cephalosporin antibiotics. The MICs against P. seudomonas and Serratia were over 400mcg/ml. 2. The mean serum levels of CTM after bolus intravenous injection of 25mg/kg were 59.9mg/ml after 15 min., 30.0mcg/ml after 30min., 15.6mcg/ml after 1 hour. 3. Administration of CTM to 6 pediatric patients produced the clinical responses which were good in all 6 cases and the bacterial effects of eradication in 3 cases and superinfection in the 2 cases in the 5 cases from whom the organism were isolated. No side effect was observed. From the above results, it is considered that a bolus injection of CTM 25 mg/kg t. i. d. to q. i. d. is a safe and useful treatment for pediatric cases.

AB - The fundamental and clinical studies on cefotiam (CTM) were performed in the field of pediatrics, and the following results were obtained: 1. The peak MICs of CTM against Gram negative rods such as E. coli, Klebsiella, Salmonella, Proteus were 1.56mcg/ml. The MIC distribution against S. aureus was almost equal to the conventional cephalosporin antibiotics. The MICs against P. seudomonas and Serratia were over 400mcg/ml. 2. The mean serum levels of CTM after bolus intravenous injection of 25mg/kg were 59.9mg/ml after 15 min., 30.0mcg/ml after 30min., 15.6mcg/ml after 1 hour. 3. Administration of CTM to 6 pediatric patients produced the clinical responses which were good in all 6 cases and the bacterial effects of eradication in 3 cases and superinfection in the 2 cases in the 5 cases from whom the organism were isolated. No side effect was observed. From the above results, it is considered that a bolus injection of CTM 25 mg/kg t. i. d. to q. i. d. is a safe and useful treatment for pediatric cases.

UR - http://www.scopus.com/inward/record.url?scp=0019439483&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019439483&partnerID=8YFLogxK

U2 - 10.11553/antibiotics1968b.34.723

DO - 10.11553/antibiotics1968b.34.723

M3 - Article

C2 - 6270415

AN - SCOPUS:0019439483

VL - 34

SP - 723

EP - 728

JO - The Journal of antibiotics. Ser. B

JF - The Journal of antibiotics. Ser. B

SN - 0368-2781

IS - 5

ER -